vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Opendoor Technologies Inc. (OPEN). Click either name above to swap in a different company.

Opendoor Technologies Inc. is the larger business by last-quarter revenue ($736.0M vs $487.7M, roughly 1.5× CLOVER HEALTH INVESTMENTS, CORP.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -148.9%, a 138.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -32.1%). Opendoor Technologies Inc. produced more free cash flow last quarter ($67.0M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -21.1%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Opendoor Technologies Inc. is an online company that buys and sells residential real estate. Headquartered in San Francisco, it makes instant cash offers on homes through an online process, makes repairs on the properties it purchases and re-lists them for sale. It also provides mobile application-based home buying services along with financing. As of November 2021, the company operates in 44 markets in the US.

CLOV vs OPEN — Head-to-Head

Bigger by revenue
OPEN
OPEN
1.5× larger
OPEN
$736.0M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+76.8% gap
CLOV
44.7%
-32.1%
OPEN
Higher net margin
CLOV
CLOV
138.8% more per $
CLOV
-10.1%
-148.9%
OPEN
More free cash flow
OPEN
OPEN
$136.0M more FCF
OPEN
$67.0M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-21.1%
OPEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
OPEN
OPEN
Revenue
$487.7M
$736.0M
Net Profit
$-49.3M
$-1.1B
Gross Margin
7.7%
Operating Margin
-10.1%
-20.4%
Net Margin
-10.1%
-148.9%
Revenue YoY
44.7%
-32.1%
Net Profit YoY
-123.2%
-869.9%
EPS (diluted)
$-1.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
OPEN
OPEN
Q4 25
$487.7M
$736.0M
Q3 25
$496.6M
$915.0M
Q2 25
$477.6M
$1.6B
Q1 25
$462.3M
$1.2B
Q4 24
$337.0M
$1.1B
Q3 24
$331.0M
$1.4B
Q2 24
$356.3M
$1.5B
Q1 24
$346.9M
$1.2B
Net Profit
CLOV
CLOV
OPEN
OPEN
Q4 25
$-49.3M
$-1.1B
Q3 25
$-24.4M
$-90.0M
Q2 25
$-10.6M
$-29.0M
Q1 25
$-1.3M
$-85.0M
Q4 24
$-22.1M
$-113.0M
Q3 24
$-9.2M
$-78.0M
Q2 24
$7.4M
$-92.0M
Q1 24
$-19.2M
$-109.0M
Gross Margin
CLOV
CLOV
OPEN
OPEN
Q4 25
7.7%
Q3 25
7.2%
Q2 25
8.2%
Q1 25
8.6%
Q4 24
7.8%
Q3 24
24.5%
7.6%
Q2 24
30.3%
8.5%
Q1 24
23.6%
9.7%
Operating Margin
CLOV
CLOV
OPEN
OPEN
Q4 25
-10.1%
-20.4%
Q3 25
-4.9%
-7.4%
Q2 25
-2.2%
-0.8%
Q1 25
-0.3%
-4.9%
Q4 24
-6.4%
-8.7%
Q3 24
-2.7%
-4.9%
Q2 24
2.0%
-4.8%
Q1 24
-6.5%
-7.4%
Net Margin
CLOV
CLOV
OPEN
OPEN
Q4 25
-10.1%
-148.9%
Q3 25
-4.9%
-9.8%
Q2 25
-2.2%
-1.9%
Q1 25
-0.3%
-7.4%
Q4 24
-6.6%
-10.4%
Q3 24
-2.8%
-5.7%
Q2 24
2.1%
-6.1%
Q1 24
-5.5%
-9.2%
EPS (diluted)
CLOV
CLOV
OPEN
OPEN
Q4 25
$-1.42
Q3 25
$-0.12
Q2 25
$-0.04
Q1 25
$-0.12
Q4 24
$-0.16
Q3 24
$-0.11
Q2 24
$-0.13
Q1 24
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
OPEN
OPEN
Cash + ST InvestmentsLiquidity on hand
$78.3M
$962.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$1.0B
Total Assets
$541.0M
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
OPEN
OPEN
Q4 25
$78.3M
$962.0M
Q3 25
$962.0M
Q2 25
$789.0M
Q1 25
$559.0M
Q4 24
$194.5M
$679.0M
Q3 24
$288.0M
$837.0M
Q2 24
$254.8M
$809.0M
Q1 24
$208.3M
$990.0M
Stockholders' Equity
CLOV
CLOV
OPEN
OPEN
Q4 25
$308.7M
$1.0B
Q3 25
$340.9M
$811.0M
Q2 25
$344.2M
$631.0M
Q1 25
$336.1M
$645.0M
Q4 24
$341.1M
$713.0M
Q3 24
$342.2M
$801.0M
Q2 24
$324.9M
$845.0M
Q1 24
$292.5M
$899.0M
Total Assets
CLOV
CLOV
OPEN
OPEN
Q4 25
$541.0M
$2.4B
Q3 25
$559.7M
$2.7B
Q2 25
$575.0M
$2.9B
Q1 25
$583.7M
$3.3B
Q4 24
$580.7M
$3.1B
Q3 24
$653.0M
$3.4B
Q2 24
$674.2M
$3.4B
Q1 24
$671.8M
$3.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
OPEN
OPEN
Operating Cash FlowLast quarter
$-66.9M
$70.0M
Free Cash FlowOCF − Capex
$-69.0M
$67.0M
FCF MarginFCF / Revenue
-14.1%
9.1%
Capex IntensityCapex / Revenue
0.4%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
OPEN
OPEN
Q4 25
$-66.9M
$70.0M
Q3 25
$12.1M
$435.0M
Q2 25
$5.4M
$823.0M
Q1 25
$-16.3M
$-279.0M
Q4 24
$34.8M
$-80.0M
Q3 24
$50.0M
$62.0M
Q2 24
$44.8M
$-399.0M
Q1 24
$25.9M
$-178.0M
Free Cash Flow
CLOV
CLOV
OPEN
OPEN
Q4 25
$-69.0M
$67.0M
Q3 25
$11.4M
$432.0M
Q2 25
$4.8M
$821.0M
Q1 25
$-16.5M
$-283.0M
Q4 24
$33.3M
$-83.0M
Q3 24
$49.6M
$56.0M
Q2 24
$44.4M
$-407.0M
Q1 24
$25.5M
$-186.0M
FCF Margin
CLOV
CLOV
OPEN
OPEN
Q4 25
-14.1%
9.1%
Q3 25
2.3%
47.2%
Q2 25
1.0%
52.4%
Q1 25
-3.6%
-24.5%
Q4 24
9.9%
-7.7%
Q3 24
15.0%
4.1%
Q2 24
12.5%
-26.9%
Q1 24
7.3%
-15.7%
Capex Intensity
CLOV
CLOV
OPEN
OPEN
Q4 25
0.4%
0.4%
Q3 25
0.1%
0.3%
Q2 25
0.1%
0.1%
Q1 25
0.0%
0.3%
Q4 24
0.5%
0.3%
Q3 24
0.1%
0.4%
Q2 24
0.1%
0.5%
Q1 24
0.1%
0.7%
Cash Conversion
CLOV
CLOV
OPEN
OPEN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons